ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LISA NOYES-DUGUAY M.D.

Internal Medicine

845

$75.3K

80
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$89
Average prescription price

Avg: $51

KRISTAL YOUNG M.D.

Internal Medicine

863

$53.7K

62
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $51

IRIS TONG MD

Internal Medicine

876

$35.3K

106
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

VENKATA RAJESH KONJETI M.D.

Internal Medicine

876

$39.9K

78
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $51

PATRICK LEVESQUE M.D.

Internal Medicine

894

$52.7K

53
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $51

MICHAEL NISSENSOHN M.D.

Internal Medicine

914

$72.9K

165
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$80
Average prescription price

Avg: $51

WILLY SALAS SANCHEZ MD

Internal Medicine

922

$36.4K

148
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$39
Average prescription price

Avg: $51

TARIQ MALIK MD

Internal Medicine

937

$38.8K

170
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $51

AYMAN ATTIA-ALLA MD

Internal Medicine

954

$46.7K

309
205 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

IRENE CHLIWNER MD

Internal Medicine

968

$47.3K

79
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

SHEENAGH BODKIN MD

Internal Medicine

980

$33K

84
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$34
Average prescription price

Avg: $51

BRIAN MONTAGUE DO

Internal Medicine

1,004

$567K

55
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 22%

$565
Average prescription price

Avg: $51

ERIC NEWTON MD

Internal Medicine

1,028

$85K

177
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 22%

$83
Average prescription price

Avg: $51

DANA CHOFAY MD

Internal Medicine

1,085

$61.7K

100
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $51

CAROLINA FONSECA VALENCIA M.D.

Internal Medicine

1,128

$40.4K

61
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $51

CHRISTINE DUFFY MD

Internal Medicine

1,155

$37.2K

171
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 22%

$32
Average prescription price

Avg: $51

MINDY SOBOTA M.D.

Internal Medicine

1,176

$51.5K

93
22 are 65+

29%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $51

MARISA VANPOZNAK MD

Internal Medicine

1,217

$61K

80
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

H. DENMAN SCOTT MD

Internal Medicine

1,221

$63.8K

46
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

FADI AL-BILBEISI M.D.

Internal Medicine

1,227

$177K

143
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

77%
prescriptions for brand name drugs

Avg: 22%

$144
Average prescription price

Avg: $51

KARA NUGENT MD

Internal Medicine

1,272

$73.8K

136
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $51

LEVIS GUZMAN M.D

Internal Medicine

1,296

$87.5K

72
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $51

SUSAN OLIVERIO MD

Internal Medicine

1,323

$58K

169
100 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $51

JONATHAN MARTIN M.D.

Internal Medicine

1,331

$90.1K

154
109 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $51

SOMASUNDARAM PANNEERSELVAM M.D.

Internal Medicine

1,353

$93K

64
22 are 65+

22%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$69
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank